Indivior plc has announced a recommended proposal to undertake a corporate reorganization by establishing Indivior Pharmaceuticals, Inc. as the new holding company of the Indivior Group. This restructuring will be implemented by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006. Shareholders are invited to vote on the proposal at a Court Meeting and an Extraordinary General Meeting, both scheduled to take place at the offices of Freshfields LLP in London on December 11, 2025. The Indivior Board has unanimously recommended that shareholders vote in favor of the scheme and related resolutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-052210), on November 14, 2025, and is solely responsible for the information contained therein.